| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1486507A1 Transmembrane nfat inhibitory peptide |
| 12/15/2004 | EP1486505A1 Angiotensin derivatives |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1486211A1 Compositions for treating cancer using viruses |
| 12/15/2004 | EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis |
| 12/15/2004 | EP1486206A1 New uses for amino acid anticonvulsants for treatment of bipolare disorder |
| 12/15/2004 | EP1486205A1 New uses for amino acid anticonvulsants for treatment of migraine |
| 12/15/2004 | EP1486182A2 A device for delivering a preselected molecule into the systemic circulation |
| 12/15/2004 | EP1485497A2 Ricin vaccine and methods of making and using thereof |
| 12/15/2004 | EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 12/15/2004 | EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines |
| 12/15/2004 | EP1485487A2 Cartilage regeneration using chondrocyte and tgf-beta |
| 12/15/2004 | EP1485483A1 Proteolysis resistant active vegf |
| 12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
| 12/15/2004 | EP1485476A2 Dimeric tf antagonist |
| 12/15/2004 | EP1485472A2 Crystal structure of an aurora kinase catalytic domain, and uses thereof |
| 12/15/2004 | EP1485466A2 Methods for treating diseases or conditions with peptide constructs |
| 12/15/2004 | EP1485413A2 Biologically active complex |
| 12/15/2004 | EP1485412A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 12/15/2004 | EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
| 12/15/2004 | EP1485409A1 Compositions isolated from bovine mammary gland and methods for their use |
| 12/15/2004 | EP1485408A2 Mutagenesis of aspergillus fungi and genes essential for growth |
| 12/15/2004 | EP1485405A2 Melanin-concentrating hormone analogs |
| 12/15/2004 | EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications |
| 12/15/2004 | EP1485400A2 Human rnase iii and compositions and uses thereof |
| 12/15/2004 | EP1485346A1 Novel positively charged lipids and liposomes comprising the positively charged lipids |
| 12/15/2004 | EP1485345A2 Urokinase inhibitors, production and use thereof |
| 12/15/2004 | EP1485138A1 Medical device for delivering biologically active material |
| 12/15/2004 | EP1485127A2 Administration of agents for the treatment of inflammation |
| 12/15/2004 | EP1485122A2 Novel application of vaccination against tnf-alpha |
| 12/15/2004 | EP1485121A2 Activated protein c formulations |
| 12/15/2004 | EP1485120A1 Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds |
| 12/15/2004 | EP1485119A1 Enhancing the availability of minerals by using biologically active peptides |
| 12/15/2004 | EP1485118A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 12/15/2004 | EP1485117A2 Methods for therapeutic treatment of benign prostatic hypertrophy (bph) |
| 12/15/2004 | EP1485116A2 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| 12/15/2004 | EP1485115A2 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers |
| 12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485073A2 Method for administration of growth hormone via pulmonary delivery |
| 12/15/2004 | EP1485070A1 Pharmaceutical microparticles |
| 12/15/2004 | EP1485069A2 Method and apparatus for producing dry particles |
| 12/15/2004 | EP1485068A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 12/15/2004 | EP1485066A1 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 12/15/2004 | EP1484977A2 Compositions and methods for treating mdma-induced toxicity |
| 12/15/2004 | EP1421204A4 Iap binding peptides and assays for identifying compounds that bind iap |
| 12/15/2004 | EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 12/15/2004 | EP1357932B1 Crystal modification of a cyclic depsipeptide having improved strength |
| 12/15/2004 | EP1263779B1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 12/15/2004 | EP1259248B1 Methods for treating cancers expressing vascular endothelial growth factor d |
| 12/15/2004 | EP1237566B1 Intraspinal compositions containing botulinum toxin for treating pain |
| 12/15/2004 | EP1226160B1 Novel antiarrhythmic peptides |
| 12/15/2004 | EP1224221B1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 12/15/2004 | EP1221964A4 Antigenic modification of polypeptides |
| 12/15/2004 | EP1221937B1 Hybrid matrices and hybrid matrix mixtures |
| 12/15/2004 | EP1207899B1 Treatment of allergic rhinitis with certain vasoactive amine binding proteins |
| 12/15/2004 | EP1175222B1 Monthly doses of glycopeptide antibiotics for long-term prevention of streptococcus pneumoniae infections |
| 12/15/2004 | EP1128838A4 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 12/15/2004 | EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 12/15/2004 | EP1115295A4 Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability |
| 12/15/2004 | EP1028752B1 Platelet substitutes and conjugation methods suitable for their preparation |
| 12/15/2004 | EP1015022B1 New improved formulation for treatment of thromboembolism |
| 12/15/2004 | EP0969816B1 Preparation of powder agglomerates |
| 12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/15/2004 | EP0932666B1 Map kinases: polypeptides, polynucleotides and uses thereof |
| 12/15/2004 | EP0929270B1 Oral peptide pharmaceutical products |
| 12/15/2004 | EP0921785B1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 12/15/2004 | EP0869816B1 Dry compositions comprising hydrophobic stabilizers |
| 12/15/2004 | EP0850310B1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 12/15/2004 | EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 12/15/2004 | EP0638088B1 Hybrid human/porcine factor viii |
| 12/15/2004 | CN1555488A Lymphatic endothelial cells materials and methods |
| 12/15/2004 | CN1555487A A process for the isolation of a major harmful oxidant from cigarette smoke |
| 12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
| 12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
| 12/15/2004 | CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 12/15/2004 | CN1555393A Keratin-based products and methods for their production |
| 12/15/2004 | CN1555372A Pyrane derivatives as both ace- and nep- inhibitors |
| 12/15/2004 | CN1555272A Compositions and methods for modulation of immune responses |
| 12/15/2004 | CN1555271A Interleukin-12 as a veterinary vaccine adjuvant |
| 12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
| 12/15/2004 | CN1555249A Dry hemostatic compositions and methods for their preparation |
| 12/15/2004 | CN1555227A Enteral formulations |
| 12/15/2004 | CN1554665A Production process and use of epidermal cell colyone |
| 12/15/2004 | CN1554444A Endothelial cell proliferation inhibitor and method of use |
| 12/15/2004 | CN1554443A Oral liquid for increasing hemogram, enhancing immunity and inhibiting tumour in cancer radiation and chemical therapy |
| 12/15/2004 | CN1554442A Non target point tissue protective agent in radiation therapy |
| 12/15/2004 | CN1554351A Medicinal composite preparation including active vitamine d compound and its use |
| 12/15/2004 | CN1554328A Microball preparation for intestine orient releasing medicne and its preparing method |
| 12/15/2004 | CN1179976C Method for producing blood coagulation factor VIII host cell |
| 12/15/2004 | CN1179975C Scorpion peptide for treating arrhythmia and its preparing process and application |
| 12/15/2004 | CN1179972C Growth hormone secretagogues |
| 12/15/2004 | CN1179750C Recombination alpha-interferon gelatin injection |
| 12/15/2004 | CN1179749C Method for preparing tumor specific transfer factors |
| 12/15/2004 | CN1179748C Stabilized pharmaceutical composition in lyophilized form |
| 12/15/2004 | CN1179727C Epiderm specificity transfer factor |
| 12/14/2004 | US6831286 Method for determining a tilt angle of an optical pickup head |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/14/2004 | US6831196 Such as benzylsulfonyl-D-Ser-Gly-4-amidinobenzylamide, HCl salt; for treatment of malign tumors/metastatic spread |